2026-05-18 • OPEN Foundation

Truffels, therapie, tuchtrecht: Een OPEN perspectief op het grijze gebied waarin (BIG-geregistreerde) therapeuten opereren in Nederland met betrekking tot psychedelica

Policy

Op 8 mei 2026 deed het Regionaal Tuchtcollege voor de Gezondheidszorg Amsterdam uitspraak in een belangwekkende zaak, waarin de Inspectie Gezondheidszorg en Jeugd (IGJ) een klacht had ingediend tegen een klinisch psycholoog (KP). Deze werd voorwaardelijk geschorst vanwege het begeleiden van een patiënt die voorafgaand aan therapiesessies psilocybine-bevattende truffels had gebruikt. De patiënte in kwestie […] The post Truffels, therapie, tuchtrecht: Een OPEN perspectief op het grijze gebied waarin (BIG-geregistreerde) therapeuten opereren in Nederland met betrekking tot psychedelica appeared first on OPEN Foundation.

External link. We are not responsible for the content.

Read more ↗

More From OPEN Foundation

2026-05-20 • OPEN Foundation

Truffles, therapy, disciplinary law – An OPEN perspective on the grey area in which (licensed) therapists operate in the Netherlands with regard to psychedelics

Read this article in Dutch here. On May 8, 2026, the Amsterdam Healthcare Disciplinary Board ruled on a significant c...

Policy
2026-05-10 • OPEN Foundation

Science Revisits Kykeon: The Enduring Enigma of the Eleusinian Mysteries

Between approximately 1450 BCE and 392 CE, people from across the Mediterranean traveled from Athens to Eleusis(the c...

2026-04-06 • OPEN Foundation

Attachment Meets Psychedelics: What the Research Suggests So Far

A new critical literature review by Cassidy, Davis, and Rao (2026), published in Psychedelics, is the first comprehen...

Latest News

2026-05-20 • DoubleBlind Magazine

What Happens When You Feel Like Jesus After Taking Psychedelics?

Experts explain why some psychedelic trips end in claims of divinity — and when it becomes a problem. [...] Read More...

2026-05-19 • Microdosing Institute

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial

Repeated microdosing of LSD (8 to 20 μg) may help improve daily mood, specifically increasing feelings of connection,...

Microdosing Research
2026-05-19 • Microdosing Institute

It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial

Caregivers of people with advanced cancer often find that psychedelic-assisted therapy can strengthen their relations...

Microdosing Research
2026-05-19 • Microdosing Institute

Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States: A National Study

About 1 in 15 young adults in the United States reported microdosing hallucinogens in the past year.

Microdosing Research
2026-05-19 • Microdosing Institute

Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial

Low doses of psilocybin may reduce the frequency of migraine attacks, but a two-dose "pulsed" schedule did not show a...

Microdosing Research
2026-05-19 • Microdosing Institute

Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials

Microdosing psilocybin can improve the quality of creative thinking by helping people come up with more original ideas.

Microdosing Research